Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoChange DetectedRevision label updated to v3.6.5 on the page. This indicates a minor maintenance update to the study page's content or metadata.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study record revision identifier was updated from v3.6.3 to v3.6.4, indicating a small backend/content management update.SummaryDifference0.1%

- Check27 days agoChange DetectedNew update dates 2026-07-15, 2026-07-13, and 2026-07 were added. Older update dates 2025-07-02, 2025-07-01, and 2025-07 were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, reflecting a minor version bump. This does not modify study information, eligibility criteria, or any user-facing content.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a patch-level update to the published page. This change does not modify study details or user-facing functionality.SummaryDifference0.1%

- Check63 days agoChange DetectedNew help/navigation sections have been added: How to Read a Study Record, Common Questions, and How to Join a Study, and the Intervention/Treatment label has been reformatted. The page now shows Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.5%

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.